Adamis Pharmaceuticals
ADMP
#10368
Rank
NZ$12.13 M
Marketcap
NZ$1.30
Share price
0.85%
Change (1 day)
-90.32%
Change (1 year)

Earnings for Adamis Pharmaceuticals (ADMP)

Earnings in 2023 (TTM): -NZ$33.35 Million

According to Adamis Pharmaceuticals's latest financial reports the company's current earnings are NZ$5.11 Million. In 2022 the company made an earning of -NZ$42.55 Million, an increase over its 2021 earnings that were of -NZ$62.87 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Adamis Pharmaceuticals from 1995 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -NZ$33.35 Million-21.63%
2022 -NZ$42.55 Million-32.32%
2021 -NZ$62.87 Million-23.65%
2020 -NZ$82.35 Million68.74%
2019 -NZ$48.8 Million-25.61%
2018 -NZ$65.6 Million52.92%
2017 -NZ$42.9 Million9.57%
2016 -NZ$39.15 Million72.46%
2015 -NZ$22.71 Million
2013 NZ$1.64 M
2011 -NZ$8.03 Million-31.89%
2010 -NZ$11.79 Million216.42%
2009 -NZ$3.73 Million68.6%
2008 -NZ$2.21 Million-27.48%
2007 -NZ$3.05 Million-59.98%
2006 -NZ$7.62 Million-13.76%
2005 -NZ$8.83 Million-61.73%
2004 -NZ$23.07 Million-0.72%
2003 -NZ$23.24 Million
2001 -NZ$29.21 Million49.39%
2000 -NZ$19.56 Million18.07%
1999 -NZ$16.56 Million13.79%
1998 -NZ$14.56 Million89.13%
1997 -NZ$7.7 Million31.43%
1996 -NZ$5.86 Million337.5%
1995 -NZ$1.34 Million